[PDF][PDF] Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis-dependent axis

…, NS Brunetti, AS Vieira, E Mansour, RG Ulaf… - Cell metabolism, 2020 - cell.com
COVID-19 can result in severe lung injury. It remained to be determined why diabetic individuals
with uncontrolled glucose levels are more prone to develop the severe form of COVID-…

[HTML][HTML] Safety and outcomes associated with the pharmacological inhibition of the kinin–kallikrein system in severe COVID-19

E Mansour, AC Palma, RG Ulaf, LC Ribeiro… - Viruses, 2021 - mdpi.com
Background: Coronavirus disease 19 (COVID-19) can develop into a severe respiratory
syndrome that results in up to 40% mortality. Acute lung inflammatory edema is a major …

[HTML][HTML] Plasma angiotensin II is increased in critical coronavirus disease 2019

…, E Mansour, AC Palma, LC Ribeiro, RG Ulaf… - Frontiers in …, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) employs angiotensin-converting
enzyme 2 (ACE2) as its receptor for cell entrance, and studies have suggested that …

SARS-CoV-2 uses CD4 to infect T helper lymphocytes

…, LC Silva-Costa, A Palma, E Mansour, RG Ulaf… - 2020 - pesquisa.bvsalud.org
… Gustavo G. Davanzo; Laboratory of Immunometabolism, Department of Genetics,
Microbiology and Immunology, Institute of Biology, University of Campinas (UNICAMP) …

[HTML][HTML] Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized …

…, B Bombassaro, EP Araujo, AF Bernardes, RG Ulaf… - Trials, 2021 - Springer
Background SARS-CoV-2, the virus that causes COVID-19, enters the cells through a mechanism
dependent on its binding to angiotensin-converting enzyme 2 (ACE2), a protein highly …

[HTML][HTML] Rapid clinical recovery of a SARS-CoV-2 infected common variable immunodeficiency patient following the infusion of COVID-19 convalescent plasma

LC Ribeiro, BD Benites, RG Ulaf, TA Nunes… - Allergy, Asthma & …, 2021 - Springer
Background Common variable immunodeficiency is the most prevalent symptomatic
primary immunodeficiency in adults. Affected patients fail to mount an appropriate humoral …

[HTML][HTML] Outcome of SARS-CoV-2 infection in 121 patients with inborn errors of immunity: a cross-sectional study

…, S Pestana, E Mansour, RG Ulaf… - Journal of clinical …, 2021 - Springer
Purpose There is still scarce data on SARS-CoV-2 infection in patients with Inborn Errors of
Immunity (IEI) and many unresolved questions. We aimed to describe the clinical outcome of …

Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19

…, I Santos, AC Palma, TA Nunes, RG Ulaf… - Blood …, 2022 - ashpublications.org
Raisa Gusso Ulaf, Raisa Gusso Ulaf … Palma, Thyago Alves Nunes, Raisa Gusso Ulaf,
Luciana Costa Ribeiro, Ana Flavia Bernardes, Bruna Bombassaro, Sergio San Juan Dertkigil, …

Pharmacological inhibition of the kinin-kallikrein system in severe COVID-19–A proof-of-concept study

E Mansour, AC Palma, RG Ulaf, LC Ribeiro… - MedRxiv, 2020 - medrxiv.org
Coronavirus disease-19 (COVID-19) can develop into a severe respiratory syndrome that
results in up to 40% mortality. Acute lung inflammatory edema is a major pathological finding …

[HTML][HTML] Circulating levels of Ang/Tie2 and VEGF-a pathway mediators are associated with clinical severity, endothelial barrier disruption and coagulation activation in …

…, SC Huber, AC Palma, TA Nunes, RG Ulaf… - Blood, 2021 - Elsevier
Background: the pathogenesis of severe COVID-19 involves the deregulated activation of
different compartments of immunothrombosis, which are otherwise important for pathogen …